Progress in T-Cell and NK-Cell Malignancies: Introduction

L. Medeiros
April 2007
American Journal of Clinical Pathology;Apr2007, Vol. 127 Issue 4, p494
Academic Journal
No abstract available.


Related Articles

  • Cutaneous T-Cell and NK-Cell Lymphomas: The WHO-EORTC Classification and the Increasing Recognition of Specialized Tumor Types. Marsha Kinney; Dan Jones // American Journal of Clinical Pathology;May2007, Vol. 127 Issue 5, p670 

    Cases drawn from Session 5 of the 2005 Society for Hematopathology/European Association for Haematopathology Workshop on progress in T-cell and natural killer (NK)-cell malignancies are used as a framework to review the current classification of T-cell and NK-cell malignancies in skin. In...

  • Large Granular Lymphocyte Leukemia. Lubomir Sokol // Oncologist;Mar2006, Vol. 11 Issue 3, p263 

    Clonal disorders of large granular lymphocytes (LGLs) represent a spectrum of biologically distinct lymphoproliferative diseases originating either from mature T cells (CD3+) or natural killer (NK) cells (CD3–). Both subtypes, T-cell and NK-cell LGL leukemia, can manifest as indolent or...

  • Clinicopathological Features and Outcomes of T- and NK-Cell Lymphomas in European Russia. Vinogradova, Yulia E.; Kaplanskaya, Irina B.; Samoilova, Rimma S.; Vorobiev, Ivan A.; Zingerman, Boris V.; Sidorova, Yulia V.; Shklovskiy-Kordi, Nikita E.; Aitova, Lilija G.; Maryin, Dmitri C.; Morris, John C.; Varticovski, Lyuba; Vorobiev, Andrei I. // Clinical Medicine Insights: Blood Disorders;2012, Issue 5, p1 

    With the introduction of the revised World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues in 2001, many patients had to be re-evaluated for the correct diagnosis of T- and NK-cell lymphomas. Because some T-cell malignancies are associated with poor outcome, it...

  • NK-Cell Lymphomas and Leukemias: A Spectrum of Tumors With Variable Manifestations and Immunophenotype. Robert Hasserjian; Nancy Harris // American Journal of Clinical Pathology;Jun2007, Vol. 127 Issue 6, p860 

    Natural killer (NK) cells are lymphocytes that have some phenotypic and functional similarities to cytotoxic T cells but do not express the T-cell receptor complex. NK-cell malignancies may be localized or disseminated at initial examination, and most behave aggressively. The variable...

  • De Novo CD3 Negative Hepatosplenic T-cell Lymphoma: Diagnostic Challenges and Pitfalls. Harn Kapur, Lucy; Khaled, Yasser; Solh, Melhem; Ward, David; Chung-Che Chang // Archives of Pathology & Laboratory Medicine;Jul2014, Vol. 138 Issue 7, p969 

    Hepatosplenic T-cell lymphoma is a rare and aggressive peripheral T-cell malignancy that is distinctively characterized by sinusoidal infiltration of mature medium-sized T lymphocytes in the spleen and liver. The neoplastic cells are classically surface CD3+, CD2+, CD5-, CD4-, and CD8+/- and...

  • Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Iqbal, J.; Weisenburger, D. D.; Chowdhury, A.; Tsai, M. Y.; Srivastava, G.; Greiner, T. C.; Kucuk, C.; Deffenbacher, K.; Vose, J.; Smith, L.; Au, W. Y.; Nakamura, S.; Seto, M.; Delabie, J.; Berger, F.; Loong, F.; Ko, Y.-H.; Sng, I.; Liu, X.; Loughran, T. P. // Leukemia (08876924);Feb2011, Vol. 25 Issue 2, p348 

    Natural killer (NK) cell lymphomas/leukemias are rare neoplasms with an aggressive clinical behavior. The majority of the cases belong to extranodal NK/T-cell lymphoma, nasal type (ENKTL) in the current WHO classification scheme. Gene-expression profiling (GEP) of 21 ENKTL and NK-cell...

  • T-Cell and NK-Cell Posttransplantation Lymphoproliferative Disorders. Steven Swerdlow // American Journal of Clinical Pathology;Jun2007, Vol. 127 Issue 6, p887 

    Posttransplantation lymphoproliferative disorders (PTLDs) of T-cell or natural killer (NK)-cell origin are an uncommon heterogeneous group of lymphoid proliferations that fulfill the criteria for one of the T- or NK-cell lymphomas/leukemias. This report summarizes 130 T/NK-cell PTLDs reported in...

  • Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. Harabuchi, Yasuaki; Takahara, Miki; Kishibe, Kan; Moriai, Shigetaka; Nagato, Toshihiro; Ishii, Hideyuki // International Journal of Clinical Oncology;Jun2009, Vol. 14 Issue 3, p181 

    Nasal natural killer (NK)/T-cell lymphoma (NNKTL) is a clinical illness characterized by progressive unrelenting ulceration and necrosis of the nasal cavity and midline facial tissues. Histological features of the lymphoma include angiocentric and polymorphous lymphoreticular infiltrates, called...

  • The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas. Ya-Ping Chen; Kung-Chao Chang; Wu-Chou Su; Tsai-Yun Chen // Annals of Hematology;Dec2008, Vol. 87 Issue 12, p985 

    Platelet-derived growth factor receptor alpha (PDGFRA) is important in numerous malignancies and can serve as a target for therapeutic strategy. We aimed to assess the role of PDGFRA expression in mature T- and natural killer (NK)-cell lymphomas. We used immunohistochemistry to analyze PDGFRA...

  • Natural killer-cell malignancies: diagnosis and treatment. Kwong, Y.-L. // Leukemia (08876924);Dec2005, Vol. 19 Issue 12, p2186 

    Natural killer (NK)-cell malignancies are uncommon diseases. Previously known as polymorphic reticulosis or angiocentric T-cell lymphomas, they are classified by the World Health Organization as NK/T-cell lymphoma, nasal type and aggressive NK-cell leukemia. They are prevalent in Asia and South...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics